Disease Spotlight Adaptations and positivity are key to living in the light wi... It took 30 years for Krister Inde to find out the visual impairment that developed when he was 19 was caused by the rare genetic condition LHON.
News EC clears first treatment for high-risk smouldering multiple... Johnson & Johnson’s Janssen-Cilag has secured European Commission approval for a new indication of its subcutaneous formulation of DARZALEX
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face